Investors

Date	Name	Title	Type	Shares Traded	Price Range
May 14, 2013	aberman michael s	Officer	Automatic Sell	5,529	278.72 - 281.72
May 13, 2013	aberman michael s	Officer	Option Execute	12,500	24.00
May 20, 2013	goldberg murray a	Officer	Automatic Sell	81,132	266.64
May 21, 2013	goldberg murray a	Officer	Disposition (Non Open Market)	4,061	n/a
May 20, 2013	goldberg murray a	Officer	Option Execute	147,967	16.80 - 53.18
May 21, 2013	goldberg murray a	Officer	Option Execute	4,023	16.80 - 20.32
May 21, 2013	goldberg murray a	Officer	Automatic Sell	66,835	255.52 - 264.61
Jan 16, 2013	goldberg murray a	Officer	Automatic Sell	7,878	170.57 - 174.56
Nov 21, 2012	goldberg murray a	Officer	Disposition (Non Open Market)	250	n/a
Dec 3, 2012	goldberg murray a	Officer	Disposition (Non Open Market)	14,500	n/a
Dec 3, 2012	goldberg murray a	Officer	Acquisition (Non Open Market)	14,500	n/a
Dec 7, 2012	goldberg murray a	Officer	Disposition (Non Open Market)	4,250	n/a
Dec 10, 2012	goldberg murray a	Officer	Disposition (Non Open Market)	6,100	n/a
Dec 14, 2012	goldberg murray a	Officer	Automatic Sell	4,607	179.13
Dec 17, 2012	goldberg murray a	Officer	Disposition (Non Open Market)	3,400	n/a
Dec 17, 2012	goldberg murray a	Officer	Option Execute	1,850	20.32
Nov 13, 2012	goldberg murray a	Officer	Automatic Sell	11,557	144.36 - 148.05
Nov 14, 2012	goldberg murray a	Officer	Automatic Sell	3,156	147.65 - 149.18
Nov 13, 2012	goldberg murray a	Officer	Option Execute	8,176	8.50 - 65.76
May 21, 2012	goldberg murray a	Officer	Option Execute	16,244	11.64 - 21.92
Showing 21-40 of 633 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.